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inherited fragile X premutations (MIP). Daughters of
normal transmitting males all have PIP, sisters of pro-
bands never have PIP, mothers of probands have a
ratio of nearly 3:1, and so forth (Morton and Mac-
pherson 1992). Neither the present study nor the
study by Hundscheid et al. categorizes relationship,
which presumably accounts for the observed differ-
ence in frequencies; however, this is irrelevant if sur-
vival analysis is used correctly. In both studies, all
subjects were interviewed and hearsay evidence was
rejected. In an unspecified proportion of cases,
Hundscheid et al. obtained age at menopause from
medical records, whereas we accepted the subject’s
recall. Our definitions of POF, spontaneous meno-
pause, unnatural menopause, menstrual history, and
medication are indistinguishable from those of
Hundscheid et al. We based our classification of MIP
and PIP on several microsatellites in the FRAXA re-
gion, classifying 25 cases as being of unknown origin,
according to conservative criteria. Hundscheid et al.
did not specify whether markers were tested, how
their classification was made, or how many subjects
were unclassifiable. Regardless of whether this is con-
sequential, the fact remains that we observed a sig-
nificant difference between women with MIP and con-
trol individuals (log-rank ; ),2x = 8.52 P = .00351
whereas Hundscheid et al. did not. We are unable to
explain this difference.
It would be very interesting to know whether other
investigators find parent-of-origin differences in the fre-
quency of POF in premutation carriers. As in all recent
studies, the protocol should include interviews of all
available female relatives, with rigorous definition of
menopausal variables and mode of origin and with cor-
rect use of survival analysis. Only then will studies by
different groups pass from debate to discovery.
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Premature Ovarian Failure Is Associated with
Maternally and Paternally Inherited Premutation in
Brazilian Families with Fragile X
To the Editor:
Strong evidence has been produced that indicates FMR1
premutation as a risk factor for premature ovarian fail-
ure (POF) (Cronister et al. 1991; Schwartz et al. 1994;
Vianna-Morgante et al. 1996, 1999; Murray et al. 1998;
Uzzielli et al. 1999). The most extensive survey was a
collaborative study engaging nine centers in different
countries that showed that 16% of women with pre-
mutation suffered POF compared with 0.4% of their
noncarrier relatives (Allingham-Hawkins et al. 1999). In
a recent study of Dutch families with fragile X, Hund-
scheid et al. (2000) disclosed a parent-of-origin effect of
the premutation such that POF occurred with a signif-
icant frequency only in women who inherited the pre-
mutation from their fathers.
We investigated parental origin of the premutation
and occurrence of POF in 113 female carriers in families
with fragile X, ascertained through mentally retarded
patients. In these families, women aged 25 years who
had been tested for the fragile X mutation were inter-
viewed personally by one of us (A.M.V.-M.) about their
menstrual, gynecological, and reproductive histories, af-
ter appropriate informed consent. Those who had un-
dergone hysterectomy or oophorectomy were not in-
cluded in the study. POF was defined as spontaneous
cessation of menstruation at age !40 years, for at least
1 year. Part of the present sample was included in our
previous study of the frequency of POF in fragile X
carriers (Vianna-Morgante et al. 1999). Parental origin
of the premutation could be determined in 59/113
women: 27 of the premutations were maternally inher-
ited (MIP) and 32 were paternally inherited (PIP). The
27 women with a MIP belonged to 21 sibships (aver-
age 1.29 daughters, range 1–3 daughters), and the 32
women with a PIP belonged to 19 sibships (average 1.68
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Table 1
Characteristics of Women Carrying an FMR1 PIP or MIP and Their Noncarrier Relatives










Mean age, years 39.18  7.03 39.84  12.89 39.20  12.35
Mean age at menopause, years 36.50  9.85 (n = 13) 34.67  11.96 (n = 9) 50.67  5.07 (n = 9)
POF (40 years) 5/15 2/10 0/50
POF (!40 years) 4/17 3/17 0/50
POF (all ages) 9/32 5/27 0/50
daughters, range 1–5 daughters). Age at examination did
not differ between the two groups (medians: MIP, 36.83;
PIP, 38.875; [Mann-Whitney test]). AmongP = .5328
women with a MIP, five had experienced POF, and it
occurred in nine women with a PIP, a difference that
was not statistically significant ( [Fisher’s exactP = .5411
test]). Age at menopause in the two groups did not differ
either (medians: MIP, 38 [ ]; PIP, 35 [ ];n = 9 n = 13 P =
[Mann-Whitney test]) but were significantly lower1.0
than age at menopause among 50 of their relatives who
carried normal alleles (median age: 51 years [ ];n = 9
[Kruskal Wallis test]). These results are sum-P = .0014
marized in table 1.
In conclusion, our data do not support the hypothesis
of a parent-of-origin effect of the FMR1 premutation
on ovarian function such that only the paternally in-
herited premutation is significantly associated with POF.
The association of POF with PIP and MIP in one ped-
igree as shown by Vianna-Morgante et al. (1996) further
denies an effect confined to paternally inherited pre-
mutation. The finding of a possible genomic imprinting
effect, reported by Hundscheid et al. (2000), may be
peculiar to the Dutch population. Otherwise the differ-
ence between theirs and the present survey may be the
result of an undiagnosed ascertainment bias. Data on
other populations are urgently needed, if only consid-
ering their implications for genetic counseling.
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